Skip to main content

Table 3 Positivity for human papillomavirus (HPV)16/18 among 2508 women, according to cytological findings and HIV status. Rwanda, 2013–2014

From: Human papillomavirus infection in Rwanda at the moment of implementation of a national HPV vaccination programme

Cytology

HIV negative

HIV positive

Total

N

HPV16/18-pos n (%)

N

HPV16/18-pos n (%)

N

HPV16/18-pos n (%)

Normal

1749

91 (5.2)

387

26 (6.7)

2136

117 (5.5)

ASCUS/ASC-H/LSIL

146

26 (17.8)

64

8 (12.5)

210

34 (16.2)

HSIL

27

11 (40.7)

18

7 (38.9)

45

18 (40.0)

 

p-value for heterogeneity by HIV statusa = 0.33

  
  1. alog-likelihood ratio test (see methods)